Recursion Pharmaceuticals, Inc. (RXRX)
Salt Lake City, UT
Total Compensation for Fiscal Year Ending in 2024: $8,499,587
| Salary | $600,000 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $3,364,500 |
| Value of Option Awards | $4,274,816 |
| Non-Equity Incentive Plan Compensation | $241,865 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $18,405 |
| Total | $8,499,587 |
Recursion Pharmaceuticals, Inc. disclosed its CEO pay was
28
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
